European Medicines Agency recommends approval of first-in-class treatment for metastatic or unresectable melanoma

View source ↗

Summary

EMA recommends approval of a first-in-class treatment for metastatic or unresectable melanoma, indicating a new mechanism is being brought to patients in this i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Melanoma